From: Human mesenchymal stromal/stem cells acquire immunostimulatory capacity upon cross-talk with natural killer cells and might improve the NK cell function of immunocompromised patients
Controls
Patients
(n = 6)
Age (years)
32 (22–37)
25 (21–45)
Gender (male/female)
2/4
4/2
ISS
–
36 (34–43)